Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

Neuroscience Research

ARA290

In Stock

$104.00

ARA290 is a short erythropoietin-derived peptide designed to investigate tissue-response signaling separately from red-blood-cell production. Its research profile includes the proposed innate repair receptor complex, inflammation-associated nerve injury and small-fiber structure/function endpoints measured with corneal imaging, skin biopsy and sensory testing. Available options: 10mg × 10 vials. For laboratory research only—not for human or veterinary use.

99%+ Purity
Lab Tested
Fast Shipping
COA Available
SKU: N/A Category:

Description


SaiyanMed Research Material

ARA290

Innate repair receptor biology · Inflammation-associated nerve injury

ARA290 is a short erythropoietin-derived peptide designed to investigate tissue-response signaling separately from red-blood-cell production. Its research profile includes the proposed innate repair receptor complex, inflammation-associated nerve injury and small-fiber structure/function endpoints measured with corneal imaging, skin biopsy and sensory testing.

Innate repair receptor biology
Inflammation-associated nerve injury
Small-fiber imaging and sensory endpoints
Laboratory material
Research use only

RESEARCH CONTEXT

Innate repair receptor biology

A small disease-specific investigational study does not establish broad nerve regeneration, pain treatment or product safety. A 2016 erratum corrected an arithmetic error in the corneal nerve-fiber-area algorithm, so the original absolute area values are superseded by the corrected measurements.

ARA290
Batch-specific documentation
RUO

Research Context

Innate repair receptor biology

The original paper describes a proposed signaling receptor complex involving erythropoietin-receptor and beta-common receptor subunits, distinct from erythropoietic signaling.

Innate repair receptor biology
Inflammation-associated nerve injury
Small-fiber imaging and sensory endpoints

What is ARA290?

ARA290 (ARA 290; cibinetide) is an engineered 11-amino-acid erythropoietin-derived peptide investigated as a nonerythropoietic innate repair receptor agonist. ARA290 is a short erythropoietin-derived peptide designed to investigate tissue-response signaling separately from red-blood-cell production. Its research profile includes the proposed innate repair receptor complex, inflammation-associated nerve injury and small-fiber structure/function endpoints measured with corneal imaging, skin biopsy and sensory testing.

Preclinical nerve-injury and neuritis models form part of the research background discussed in the paper’s introduction; they are distinct from clinical and product-specific evidence. A small single-site, blinded placebo-controlled sarcoidosis study enrolled 38 participants and evaluated corneal nerve-fiber measurements, skin-biopsy nerve density, quantitative sensory testing and symptom questionnaires. These are investigational clinical endpoints, not product efficacy assurances.

A small disease-specific investigational study does not establish broad nerve regeneration, pain treatment or product safety. A 2016 erratum corrected an arithmetic error in the corneal nerve-fiber-area algorithm, so the original absolute area values are superseded by the corrected measurements.

🧪 Research Applications

①

Innate repair receptor biology

The original paper describes a proposed signaling receptor complex involving erythropoietin-receptor and beta-common receptor subunits, distinct from erythropoietic signaling.

②

Inflammation-associated nerve injury

Preclinical nerve-injury and neuritis models form part of the research background discussed in the paper’s introduction; they are distinct from clinical and product-specific evidence.

③

Small-fiber imaging and sensory endpoints

A small single-site, blinded placebo-controlled sarcoidosis study enrolled 38 participants and evaluated corneal nerve-fiber measurements, skin-biopsy nerve density, quantitative sensory testing and symptom questionnaires. These are investigational clinical endpoints, not product efficacy assurances.

④

Analytical Characterization

Assess material identity, composition, and method suitability using documentation for the exact sample; published research does not certify the commercial lot.

⑤

Study Interpretation

Interpret experimental results within the tested model and endpoint. Constituent or reference-compound findings do not establish clinical effects of this material.

⑥

Material Traceability

Match laboratory records and any supplier report to the exact labeled material and lot.

📊 Quick Specs

Product: ARA290
Available options: 10mg × 10 vials
Reference identity: Cibinetide / ARA290
Sequence (reference): {Glp}-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser ({Glp}-EQLERALNSS)
Peptide length: 11 amino-acid residues
CAS Number (reference): 1208243-50-8
Molecular formula (reference): C51H84N16O21
Molecular weight (reference): 1257.31 g/mol
Structure / chemical form: N-terminal pyroglutamyl (Glp), not an uncyclized N-terminal Gln/Q peptide. Reference formula excludes acetate/counterions.

Molecular parameters describe the stated reference chemical form; pack sizes and blend amounts are supplier declarations. The received lot label and SDS take precedence. Reference handling guidance is not a batch-purity certificate or a guaranteed shelf life.

Quality Documentation

Certificate of Analysis (COA)

A Certificate of Analysis records the identity checks, analytical methods and results reported for a specific sample or batch. Explore published quality reports in the SaiyanMed Trust Center.

For product or batch documentation enquiries, contact SaiyanMed with the product name and lot number, where available.

📦 Storage & Handling

Dry reference peptide

For the reference powder: store at −20°C, tightly sealed and protected from moisture.

Prepared research solutions

Use a solvent compatible with the peptide and assay. The reference datasheet lists −20°C or −80°C for frozen stock storage, depending on the conditions. Divide stocks into single-use aliquots and avoid repeated freeze–thaw cycles. Validate stability for the actual solvent and concentration rather than assigning a universal solution expiry.

Opening cold dry vials

For a cold dry/lyophilized sample, allow the closed vial to reach ambient temperature in a desiccator before opening. Handle promptly and reseal tightly to limit condensation and moisture uptake.

🚚 Fulfillment & Transit Notice

Global logistics: Orders ship from the nearest available warehouse. US-based warehouse fulfillment is available for domestic US orders; international orders ship from our Asian logistics hub with an estimated 7–14 day global delivery window. Delivery estimates may vary with destination, carrier and customs processing.

Temperature in transit: Follow the storage and handling guidance for the product’s supplied form upon arrival. Dry peptides, prepared solutions and liquid formulations have different handling requirements; contact us with the product and order reference if you have concerns about transit conditions.

Customs & duties: Cross-border research-chemical shipments may occasionally be subject to customs inspection or delay. Import duties and local customs requirements remain the responsibility of the consignee. A customs hold does not by itself indicate a product issue.

Delays or holds: If a shipment is delayed beyond the estimated window or held in customs, contact us with your order reference. We will assist with tracking and, where applicable, arrange a reshipment in line with our shipping policy.

Damaged or incorrect items: Please inspect your order on arrival. If a vial is damaged or an item is incorrect, contact us within the period stated in our shipping policy, with photos, for prompt resolution.

⚠️

Research Use Only

This material is supplied only for qualified laboratory research and is not intended for human or veterinary use.

Research Use Only

Not for Human Consumption

This listing is for laboratory research only. It is not intended for diagnostic, therapeutic, medical, disease-prevention, consumer-health, or personal use.

It is not for human consumption, medical treatment, diagnosis, disease prevention, or veterinary use.

✅ Buyer Confirmation

✓ You are a qualified researcher or acting under one’s supervision.

✓ The material will be used only for legitimate laboratory research.

✓ No human-use approval, efficacy, or safety claim is made for this listing.

✓ You are responsible for applicable laws and institutional procedures.

No Warranty: Product-specific identity, quality, safety, and suitability are not independently established by this page. Research outcomes and interpretations depend on the material and study design.

🛡️ General Safety & Handling

🚫 Not for Human Use
For qualified laboratory research only; not for human or veterinary administration.

🥽 PPE Required
Use appropriate personal protective equipment and institutional laboratory controls.

🌡 Follow Lot Documentation
Product-specific storage and stability details are not supplied on this listing.

🗑 Proper Disposal
Follow institutional biosafety and waste-disposal procedures.

🧾 Verify the Lot
Do not assume product identity or purity without batch-matched documentation.

⚖ Legal Compliance
Researchers are responsible for lawful possession and use in their jurisdiction.

💬 Frequently Asked Questions

Can ARA290 replace erythropoietin in a red-blood-cell production experiment?+

No—ARA290 is a short derivative designed to separate tissue-response research from erythropoietin’s red-blood-cell production activity. Choose an appropriate erythropoietin material if red-blood-cell production is the endpoint.

Is ARA290 beginning with Gln equivalent to the pyroglutamyl form?+

No—an uncyclized Gln terminus and a pyroglutamyl terminus are different chemical forms. For a protocol specifying cibinetide, match the pyroglutamyl reference rather than assuming the rest of the matching sequence is enough.

My protocol says cibinetide, but the product name says ARA290—do those names match?+

Cibinetide and ARA290 are names used for the same reference peptide. Check the complete sequence and terminal form when matching the product to the protocol.

Does the mg figure on the ARA290 pack mean per vial or for the whole pack?+

In the listed mg × vial-count format, the mg figure is the stated amount per vial and the count is the number of vials. Use both figures when planning the total material needed; neither figure is a solution concentration.

📚 References

ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber Density (2013; PMID 24136731)
Read source ↗

Reference context only; not a certificate or batch test for this product.

Erratum to ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber Density (2016; PMID 28059429)
Read source ↗

Reference context only; not a certificate or batch test for this product.

Specification & handling references

MedChemExpress — Cibinetide / ARA290 Product Data Sheet
Technical reference ↗
Bachem — Handling and Storage Guidelines for Peptides
Technical reference ↗

Additional information

Concentration & Vial

10mg × 10 vials

Reviews

There are no reviews yet.

Be the first to review “ARA290”

Your email address will not be published. Required fields are marked *